UBS Group’s VirnetX Holding VHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-30
Closed -$4K – 10313
2014
Q3
$4K Sell
30
-240
-89% -$64.3K ﹤0.01% 9653
2014
Q2
$95K Buy
270
+135
+100% +$41.1K ﹤0.01% 6005
2014
Q1
$38K Sell
135
-80
-37% -$27.9K ﹤0.01% 7214
2013
Q4
$83K Buy
215
+40
+23% +$15.9K ﹤0.01% 6302
2013
Q3
$71K Sell
175
-405
-70% -$160K ﹤0.01% 6413
2013
Q2
$232K Hold
580
– – ﹤0.01% 4940

Other funds holding VHC

UBS Group's VHC Position: Q3 2026 in Review

UBS Group increased its VirnetX Holding (VHC) stake by 521% in Q3 2026, buying an estimated $184K and bringing the position to 17,697 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #6822.

UBS Group first reported a position in VHC in Q2 2013 and has held it in 54 quarters since. The position peaked at $1.28M in Q3 2013. 33 funds tracked by Wall St. Rank hold VHC as of Q3 2026.

  • UBS Group held 17,697 shares of VirnetX Holding worth $180K as of Q3 2026.
  • UBS Group bought 14,849 VirnetX Holding shares in Q3 2026, an estimated $184K.
  • VirnetX Holding made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6822 holding.
  • UBS Group first reported a position in VirnetX Holding in Q2 2013 and has held it in 54 quarters since.
  • UBS Group's VirnetX Holding position peaked at $1.28M in Q3 2013.
  • 33 funds tracked by Wall St. Rank held VirnetX Holding as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.